المؤلفون: Gupta S

المصدر: Vascular Health and Risk Management, Vol Volume 12, Pp 421-433 (2016)

مصطلحات موضوعية: PCSK-9, LDLc, ASVCD, Diseases of the circulatory (Cardiovascular) system, RC666-701

وصف الملف: electronic resource

Relation: https://www.dovepress.com/development-of-proprotein-convertase-subtilisinkexin-type-9-inhibitors-peer-reviewed-article-VHRM; https://doaj.org/toc/1178-2048

URL الوصول: https://doaj.org/article/879e29cdb25a429fbfe3a6585661e66d

المؤلفون: Andrew Friedman, Wolfgang Koenig, R. Scott Wright, Kausik K. Ray, Peter Wijngaard, Ulf Landmesser, Mark Jaros, Lawrence A. Leiter, John J.P. Kastelein, Orion Phase Iii Investigators, David Kallend, Frederick J. Raal, Lorena Garcia Conde, Gregory G. Schwartz

المساهمون: Vascular Medicine, ACS - Pulmonary hypertension & thrombosis, ACS - Atherosclerosis & ischemic syndromes

المصدر: Journal of the American College of Cardiology, 77(9), 1182-1193. Elsevier USA

مصطلحات موضوعية: Male, medicine.medical_specialty, Randomization, Familial hypercholesterolemia, Placebo, Hyperlipoproteinemia Type II, Subcutaneous injection, Internal medicine, medicine, Humans, Dosing, RNA, Small Interfering, Adverse effect, Aged, low-density lipoprotein cholesterol, lipid-lowering therapy, business.industry, PCSK9, Cholesterol, LDL, Middle Aged, medicine.disease, Atherosclerosis, Confidence interval, Clinical Trials, Phase III as Topic, ASVCD, Female, lipids (amino acids, peptides, and proteins), Cardiology and Cardiovascular Medicine, business, RNA silencing, inclisiran

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f44b3e7218765ce9a6d0dca06e8575d3
https://pure.amc.nl/en/publications/pooled-patientlevel-analysis-of-inclisiran-trials-in-patients-with-familial-hypercholesterolemia-or-atherosclerosis(0c0e3511-2fa5-424a-967f-5ca398db563e).html